Akèy › Kansè Utèrin
Etid klinik pou Kansè Utèrin ap rekrite nan Etazini
29 etid pou Kansè Utèrin ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX8 etid
- New York City, NY6 etid
- Columbus, OH6 etid
- Boston, MA5 etid
- Philadelphia, PA5 etid
- Miami, FL5 etid
- Austin, TX5 etid
- St. Louis, MO4 etid
- Pittsburgh, PA4 etid
- Nashville, TN4 etid
- Orlando, FL4 etid
- Baltimore, MD4 etid
- Chicago, IL4 etid
- West Palm Beach, FL4 etid
- Providence, RI4 etid
- San Diego, CA3 etid
- Eugene, OR3 etid
- Seattle, WA3 etid
- Minneapolis, MN3 etid
- Arlington, VA3 etid
- Miami Beach, FL3 etid
- Portland, OR3 etid
- Camden, NJ3 etid
- Indianapolis, IN3 etid
- Oklahoma City, OK3 etid
- Birmingham, AL3 etid
- Dallas, TX3 etid
- Fort Worth, TX3 etid
- Cape Coral, FL3 etid
- Baldwin Park, CA3 etid
- St. Petersburg, FL3 etid
Pa eta
- Alabama3 etid
- Arizona3 etid
- Florid7 etid
- Georgia3 etid
- Illinois5 etid
- Indiana3 etid
- Kalifòni9 etid
- Maryland5 etid
- Massachusetts5 etid
- Michigan3 etid
- Minnesota5 etid
- Missouri5 etid
- New Jersey6 etid
- New York8 etid
- North Carolina4 etid
- Ohio6 etid
- Oklahoma4 etid
- Oregon4 etid
- Pennsylvania7 etid
- Rhode Island4 etid
- Tennessee4 etid
- Texas10 etid
- Virginia4 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT06952660Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT04038619PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 17, 2026 · NCT05758688Sentinel Node Biopsy in Endometrial Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Sep 15, 2026 · NCT04073706DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Sep 3, 2026 · NCT06989112Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Ap rekriteEtid obsèvasyon
Laj 18 a 50 · Fanm · Mizajou Sep 2, 2026 · NCT06904365Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Aug 27, 2026 · NCT06492070PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT04329494Investigations of Reproductive Cancers in Women
Ap rekriteEtid obsèvasyon
Laj 45 a 100 · Fanm · Mizajou Aug 17, 2026 · NCT06527157Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Fanm · Mizajou Aug 13, 2026 · NCT06040970Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366Hypofractionated Radiochemotherapy
Ap rekriteFaz 2
Laj 18 a 120 · Fanm · Mizajou Jul 30, 2026 · NCT06331468Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Jul 29, 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT07106359[18F]FES PET/.CT in Uterine Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Jun 5, 2026 · NCT05916196Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Ap rekrite
Laj 60 ak plis · Fanm · Mizajou May 29, 2026 · NCT05743517Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou May 6, 2026 · NCT05049538Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Fanm · Mizajou Apr 15, 2026 · NCT05559879Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Mar 24, 2026 · NCT05990426Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Fanm · Mizajou Mar 6, 2026 · NCT05977621Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Mar 2, 2026 · NCT06369155With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Ap rekrite
Laj 21 ak plis · Fanm · Mizajou Feb 25, 2026 · NCT05721976Sample Collection for Ongoing Research and Product Evaluation Study
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 15, 2026 · NCT07318051Image-Guided Gynecologic Brachytherapy
Ap rekrite
Laj 18 a 100 · Fanm · Mizajou Dec 18, 2025 · NCT02993900Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.